Legend Biotech’s (LEGN) “Neutral” Rating Reiterated at Guggenheim
Legend Biotech (NASDAQ:LEGN – Get Free Report)‘s stock had its “neutral” rating restated by analysts at Guggenheim in a report issued on Wednesday,Benzinga reports. A number of other research firms also recently issued reports on LEGN. HC Wainwright raised their target price on Legend Biotech from $73.00 to $75.00 and gave the stock a “buy” […]
Legend Biotech (NASDAQ:LEGN – Get Free Report)‘s stock had its “neutral” rating restated by analysts at Guggenheim in a report issued on Wednesday,Benzinga reports. A number of other research firms also recently issued reports on LEGN. HC Wainwright raised their target price on Legend Biotech from $73.00 to $75.00 and gave the stock a “buy” […]
